(Q44020464)

29 November 2017

Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis (English)

1 reference

29 November 2017

0 references

1

1 reference

29 November 2017

A S Detsky

2

1 reference

PubMed ID

8433635

29 November 2017

language of work or name

1 reference

1 January 1993

1 reference

29 November 2017

Medical Decision Making

1 reference

29 November 2017

13

1 reference

29 November 2017

4-20

1 reference

29 November 2017

1

1 reference

Hepatitis B virus. The major etiology of hepatocellular carcinoma

29 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

Toward universal vaccination against hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

Feasibility of controlling or eradicating the hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

The Markov process in medical prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

A clinician's guide to cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

Hepatitis B Surface Antigen in Blood Donors: Further Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

Vertical Transmission of Hepatitis B Antigen in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

HBeAg and anti-hbe detection by radioimmunoassay: Correlation with vertical transmission of hepatitis B virus in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

Hepatitis B vaccination of newborn infants: clinical study of new vaccine formulation and dose regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

Hepatitis B Antigen and Antibody in Blood Donors: An Epidemiologic Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

Incidence of hepatitis B virus infections in preschool children in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

Development of a sarcoma in a surgical scar

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

Incidence of hepatitis among students at a university in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

The development of cirrhosis in patients with chronic type B hepatitis: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9301300103

10.1177/0272989X9301300103

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference

PubMed ID

8433635